DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Sattar N, McLaren J, Kristensen SL. et al.
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?.
Diabetologia 2016;
59: 1333-1339
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.